/data/photo/2020/10/14/5f8711625addb.jpg?fit=%2C&ssl=1)
KOMPAS.com – The efforts of scientists and a number of countries to find a vaccine and drug for Covid-19 are still ongoing. This effort is a race against time to find a vaccine. There are 11 vaccines that are currently in phase III trials in humans. However, not all testing processes went smoothly. Several Covid-19 … Read more
Jakarta – Johnson & Johnson discontinue the candidate’s clinical trial the COVID-19 vaccine after one of the vaccine volunteers experienced ‘unexplained illness’. The volunteer health condition is being monitored and evaluated by the Data Safety Monitoring Board (DSMB). Regarding the condition of the volunteers, JNJ did not provide a more detailed explanation because it was … Read more
Johnson & Johnson said it had temporarily stopped clinical trials of a candidate vaccine for Covid-19 disease after one of the participants contracted an unexplained disease, delaying one of the most important efforts made to contain the global pandemic. The company said in a statement on Monday that an independent board to monitor data and … Read more
<div id="firstBodyDiv" data-bind-html-content-type="article" data-bind-html-compile="article.body" data-first-article-body=" The American group said in a statement: "We have temporarily discontinued additional vaccination in all of our clinical trials for an experimental vaccine against Covid 19, Including the entire third phase trial, due to an unexplained illness that one of the study participants contracted". The company did not disclose the … Read more
Jakarta, CNBC Indonesia – There’s good news about vaccines Covid-19 concoction of the company from the United States (US) Johnson & Johnson. Preliminary results from phase 2 clinical trials indicate that this vaccine is well tolerated. Even one dose appears to produce a strong immune response in nearly all of the 800 people. The trial … Read more
Johnson & Johnson announced that the covid-19 vaccine it is manufacturing produces a strong immune response in just one dose. Called Ad26.COV2.S, the vaccine was also well tolerated when administered in two doses, shows the trial that is in an intermediate phase. However, it has not been proven to be effective in protecting the elderly, … Read more
Updated 08/24/2020 at 9:10 PM – Johnson & Johnson and its pharmaceutical group Janssen confirmed that Peru will be one of the locations of its phase 3 clinical study, to evaluate the effectiveness of its candidate vaccine against COVID-19. The Ministry of Foreign Affairs indicated, through a statement, that the criteria considered by the company … Read more
In a recent article, I discussed the possibility of another stock market crash in 2020. Economic data looks absolutely terrible at the moment (the UK economy shrank by a record 20.4% in April) and stock prices simply don’t reflect that. What is worrying is that a recent survey found that almost 70% of professional wealth … Read more
The French L’Oréal will stop using terms referring to white, such as bleaching or light, on the packaging of its skin care products. According to Reuters, its spokesman said on Friday. The world’s largest cosmetics manufacturer is responding to growing criticism of social networks and is taking a step back after a similar announcement was … Read more
<div id = "firstBodyDiv" data-bind-html-content-type = "article" data-bind-html-compile = "article.body" data-first-article-body = " The contract, which is the largest of its kind in the world, and whose details have been revealed by “Forbes”, also includes the start of the work of the company’s division specialized in drug production, in order to reach a “new counter” … Read more